Tumor hypoxia is an important mechanism of radioresistance in hypofractionated radiotherapy and must be considered in the treatment planning process
No abstract prepared.
- OSTI ID:
- 22098683
- Journal Information:
- Medical Physics, Vol. 38, Issue 12; Other Information: (c) 2011 American Association of Physicists in Medicine; Country of input: International Atomic Energy Agency (IAEA); ISSN 0094-2405
- Country of Publication:
- United States
- Language:
- English
Similar Records
Radiation-induced nitric oxide mitigates tumor hypoxia and radioresistance in a murine SCCVII tumor model
The best radiotherapy for the treatment of prostate cancer involves hypofractionation
Direct tumor in vivo dosimetry in highly-conformal radiotherapy: A feasibility study of implantable MOSFETs for hypofractionated extracranial treatments using the Cyberknife system
Journal Article
·
Fri Aug 02 00:00:00 EDT 2013
· Biochemical and Biophysical Research Communications
·
OSTI ID:22098683
+7 more
The best radiotherapy for the treatment of prostate cancer involves hypofractionation
Journal Article
·
Fri Sep 15 00:00:00 EDT 2006
· Medical Physics
·
OSTI ID:22098683
Direct tumor in vivo dosimetry in highly-conformal radiotherapy: A feasibility study of implantable MOSFETs for hypofractionated extracranial treatments using the Cyberknife system
Journal Article
·
Thu Apr 15 00:00:00 EDT 2010
· Medical Physics
·
OSTI ID:22098683
+2 more